GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO) Professor Jones will lead the development of protein footprinting technology to study protein interactions of in vivo membrane proteins HALF MOON BAY, Calif. – January 11, 2023 – With ambitious plans to expand the reach and impact of their [...]
GenNext Technologies Announces the Appointment of Dr. John Grant from Lemnos Advisory to its Board of Directors Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise. Half Moon Bay, CA. – January 10, 2023 – GenNext Technologies, Inc., an innovative provider of laboratory tools for advanced structural characterization [...]
GenNext Technologies Earns the Coveted $250,000 Grand Prize Award at the 2022 BioTools Innovator Final Competition Company will use the award to further develop scientific instruments, software, and services that ultimately improve the safety, stability, and effectiveness of biotherapeutics. HALF MOON BAY, Calif. – October 26, 2022 - GenNext Technologies, Inc., a growth-stage company that [...]
GenNext Technologies Introduces Protein Footprinting Products to Japan through Kiko Tech Co., LTD. Kiko Tech is a premier distributor of state-of-the-art instruments and reagents for molecular diagnostics, proteomics, applied testing, pharmaceutical, and academic research since its establishment in 1974. The Kiko Tech team is excited about the opportunity to introduce the Japanese scientific community to [...]
GenNext Technologies Announces $2.5M Grant Award to Commercialize In-Cell Protein Footprinting Instrumentation GenNext will use this award to advance its intellectual property and expertise to develop a fully automated platform that will study drug-induced HOS structure changes within living cells, with its first system designed for in-vivo protein footprinting studies. HALF MOON BAY, Calif. – [...]
GenNext Technologies Announces its Second Key US Protein Footprinting Patent The United States Patent and Trademark Office (USPTO) has issued GenNext a Patent for Radical Dosimetry for the Analysis of Biopharmaceuticals and Biological Molecules. HALF MOON BAY, Calif. – December 9, 2021 – Life Science Newswire – GenNext Technologies, Inc., a growth-stage company providing instrumentation, software, and services, announced today that [...]
GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent A new patent protects GenNext's intellectual property to advance the study of biopharmaceutical Higher Order Structure (HOS). HALF MOON BAY, Calif. – April 28, 2021 – Life Science Newswire – GenNext Technologies, Inc., a growth-stage company that provides instrumentation, software, and services to structural biology [...]